Related Experiment Video
Updated: Aug 8, 2026

Murine Model of CD40-activation of B cells
Published on: March 6, 2010
Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection
M D Denton1, R M Reul, V R Dharnidharka
1Department of Pediatrics, Children's Hospital, Boston, Massachusetts 02115, USA.
Insights
CD40/CD154 interactions are crucial for immune responses and allograft rejection. Interrupting this pathway shows promise in transplantation models, paving the way for new human therapies.
Area of Science:
- Immunology
- Transplantation Biology
Background:
- CD40 and its ligand CD154 (also known as CD154) play key roles in immune system regulation.
- CD40/CD154 interactions are vital for T cell activation, macrophage activation, B cell interactions, and endothelial cell activation.
Purpose of the Study:
- To review the significance of CD40/CD154 interactions in the immune response.
- To highlight the role of CD40/CD154 in allograft rejection.
- To discuss therapeutic strategies for interrupting CD40/CD154 signaling in transplantation.
Main Methods:
- Review of major advances in understanding CD40/CD154 expression and function.
- Analysis of functional studies using blocking monoclonal antibodies in animal transplantation models.
- Examination of evidence supporting the role of CD40/CD154 in allograft rejection.
Main Results:
- CD40/CD154 interactions are critical for multiple immune processes.
- These interactions are central to the immune mechanisms of allograft rejection.
- Interrupting CD40/CD154 co-stimulation, especially with CD28/B7 pathway interruption, shows benefits in transplantation models.
Conclusions:
- Targeting the CD40/CD154 pathway is a promising therapeutic strategy for allograft rejection.
- Future research should focus on developing human receptor antagonists or understanding intracellular signaling pathways.
- Developing novel therapies to block CD40/CD154 co-stimulation is essential for improving transplantation outcomes.
Abstract:
Major advances have been made in understanding the expression and function of CD40 and its ligand CD154. It is now clear that CD40/CD154 interactions are critical in many aspects of the immune response, including T cell activation, T cell-dependent macrophage activation, T cell-B cell interactions and endothelial activation. Moreover, increasing evidence supports a central role for CD40/CD154 interactions in the immune processes of allograft rejection. Functional studies using blocking monoclonal antibodies have revealed beneficial effects of interupting CD40/CD154 co-stimulation in animal models of transplantation, particularly in association with interuption of the CD28/B7 pathway. A next step is to develop new therapeutic approaches to interrupting this pathway in humans, either through the development of receptor antagonists or through the understanding of intracellular signaling pathways utilized by these molecules.
Related Concept Videos
Cell-mediated Immune Responses
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

